Jeppe Øvli Øvlesen — CEO
Get alerts when Jeppe Øvli Øvlesen trades
Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: SynAct Pharma AB.
12-month summary
Net buyer over the last 12 months
1 open-market buy, 0 sales, 0 share awards · SEK 142,145.58 bought, SEK 0.00 sold
Roles
05.03.2026 – 05.03.2026
Transactions (including via associated entities)
| Date | Issuer | Transaction type | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 05.03.2026 | SynAct Pharma AB Stockholm | Bought — open marketAcquisition via Quantass ApS | 7,900 | SEK 17.99 | SEK 142,145.58 | ↗ |